tirzepatide stamford Retatrutide vs. Tirzepatide: The Next-Gen GLP-1 Showdown Want to learn more about

But that doesnt mean that their suffering is any less real

GLP-1 RAs exert direct and indirect effects on the CV system including vasodilation, natriuresis anti-atherosclerotic effects, improvements in endothelial function, anti-inflammatory effects (decrease cytokines level such as tumor necrosis factor, interlukin-1, interlukin-6) and a consequent decrease in C-reactive protein, and reductions in infarct size (60, 84, 85)

Mounjaro Lawsuits May Impact Growth of Eli Lilly Diet Drug Amid Stomach Paralysis Problems Although Eli Lillys recently introduced diet drug has seen rapid sales growth, a new Mounjaro lawsuit alleges that users are not adequately warned about gastrointestinal side effects that may cause stomach paralsysis Mounjaro was introduced in May 2022, as a weight loss drug for type 2 diabetes patients FDA now is reviewing the results of Mounjaro clinical trial data and could approve wider use of the drug specifically for weight loss by the end of 2023 Eli Lilly was recently hit with a Mounjaro lawsuit over stomach paralysis or gastroparesis Similar lawsuits may soon be filed by additional users, alleging drug maker failed to adequately disclose the potential Mounjaro side effects FIND OUT IF YOU QUALIFY FOR A MOUNJARO LAWSUIT As pharmaceutical giant Eli Lilly continues to seek official approval for the wider use of its potential blockbuster drug Mounjaro as a treatment for obesity in non-diabetic patients, a recently filed Mounjaro lawsuit may signal the start of a problem for the drug maker, as additional users contemplate filing claims after developing severe stomach paralysis or gastroparesis

Gastroenterology 97 (3), 575585